11C-UCB-J
Tier C — Watch / trade11C-UCB-J
Targets：SV2A
Indications (approved)：Alzheimer's disease, Cannabis dependence, Major depressive disorder
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| 11C-UCB-J-001 | - | (R)-trifluoro(4-((2-oxo-4-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)methyl)pyridin-1-ium-3-yl)borate |
| 11C-UCB-J-002 | - | (R)-(4-((2-oxo-4-(3,4,5-trifluorophenyl)pyrrolidin-1-yl)methyl)pyridin-3-yl)boronic acid |
| 11C-UCB-J | 2098041-11-1 | 2-Pyrrolidinone, 1-[[3-(methyl-11C)-4-pyridinyl]methyl]-4-(3,4,5-trifluorophenyl)-, (4R)- |
Frequently asked questions
What are the approved indications of 11C-UCB-J?
Approved indications include: Alzheimer's disease, Cannabis dependence, Major depressive disorder.
When does the 11C-UCB-J patent expire?
No public expiry year is available for 11C-UCB-J yet; this page updates once verified.
How many synthesis routes are recorded for 11C-UCB-J?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy 11C-UCB-J intermediates?
All intermediates in 11C-UCB-J routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for 11C-UCB-J intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08